A.I. Nurjabov

12 ta ish

Tashkent Pediatric Medical Institute

1. Dynamics of the incidence of non-melanoma malignant neoplasms in the Republic of Uzbekistan for the 2018–2022

   D. Polatova, D. А. Ibragimova, А. Yu. Madaminov +6

   MaqolaOAOchiq kirishCOVID-19 and healthcare impactsBone and soft tissue sarcomas tumors of the skin20230 iqtibos

   ABIABI:AkademIndex/2023.article.003255

2. 398P Evaluation of the effectiveness of denosumab therapy giant cell tumor of the pelvis

   A.I. Nurjabov, D. Polatova, D.R. Rasulbek Rakhimberdiyevich +2

   MaqolaOAOchiq kirishBone Tumor Diagnosis and TreatmentsAnnals of Oncology20230 iqtibos

   ABIABI:AkademIndex/2023.article.011843

3. Epidemiological indicators of melanoma in the Republic of Uzbekistan

   D. А. Ibragimova, D. Polatova, A.I. Nurjabov +2

   MaqolaOAOchiq kirishDiverse Scientific Research StudiesEJC Skin Cancer20240 iqtibos

   ABIABI:AkademIndex/2024.article.002328

4. 39P The possibility of predicting the effectiveness of treatment of soft tissue sarcomas on the basis of the properties of their immunologic microenvironment

   Н.К. Асамединов, D. Polatova, Nargiza Karimova +5

   MaqolaOAOchiq kirishCAR-T cell therapy researchESMO Open20240 iqtibos

   ABIABI:AkademIndex/2024.article.004816

5. 111P Oncologic outcomes of the pelvic bone tumors

   A.I. Nurjabov, N.S. Kamalovich, Н.К. Асамединов +4

   MaqolaOAOchiq kirishEndometrial and Cervical Cancer TreatmentsESMO Open20240 iqtibos

   ABIABI:AkademIndex/2024.article.005267

6. 153P The preoperative treatment of patients with giant cell tumors of limb bones by denosumab therapy

   N.S. Kamalovich, D. Polatova, K. Abdikarimov +6

   MaqolaOAOchiq kirishBone Tumor Diagnosis and TreatmentsESMO Open20240 iqtibos

   ABIABI:AkademIndex/2024.article.005268

7. 74P The influence of genetic phenotype on prognosis of osteosarcoma

   N.S. Kamalovich, D. Polatova, K. Abdikarimov +5

   MaqolaOAOchiq kirishSarcoma Diagnosis and TreatmentESMO Open20240 iqtibos

   ABIABI:AkademIndex/2024.article.008479

8. 125P Possibility of using the combination everolimus/sorafenib combination of medications in the treatment of children and adolescents with refractory osteosarcoma and Ewing sarcoma

   Н.К. Асамединов, K. Abdikarimov, D.R. Rasulbek Rakhimberdiyevich +3

   MaqolaOAOchiq kirishSarcoma Diagnosis and TreatmentESMO Open20250 iqtibos

   ABIABI:AkademIndex/2025.article.002969

9. 123P The treatment by denosumab of patients with giant cell tumors of bones

   N.S. Kamalovich, D. Polatova, K. Abdikarimov +5

   MaqolaOAOchiq kirishBone Tumor Diagnosis and TreatmentsESMO Open20250 iqtibos

   ABIABI:AkademIndex/2025.article.004201

10. 137P Treatment of inoperable or locally advanced giant cell tumor of bone

    A.I. Nurjabov, K. Abdikarimov, D. Polatova +5

    MaqolaOAOchiq kirishBone Tumor Diagnosis and TreatmentsESMO Open20250 iqtibos

    ABIABI:AkademIndex/2025.article.004202

11. The preoperative management of patients with giant cell tumors in limb bones using denosumab therapy.

    S. K. Nasirov, D. Polatova, Khurshid Abdikarimov +7

    MaqolaOAOchiq kirishBone Tumor Diagnosis and TreatmentsJournal of Clinical Oncology20250 iqtibos

    ABIABI:AkademIndex/2025.article.005585

12. Possibility of using the combination of everolimus/sorafenib medications in the treatment of children and adolescents with refractory osteosarcoma and Ewing sarcoma.

    Н.К. Асамединов, Jamila Polatova, Khurshid Abdikarimov +7

    MaqolaOAOchiq kirishSarcoma Diagnosis and TreatmentJournal of Clinical Oncology20250 iqtibos

    ABIABI:AkademIndex/2025.article.005599